In arrhythmogenic cardiomyopathy, characterized by fibrofatty replacement of the myocardium, diagnostic efforts are difficult and many different steps are required to provide an accurate diagnosis.
In case of diagnosis standard ECG, echocardiography, right ventricular angiography and electrophysiological examination can provide strong diagnostic evidence.
The most relevant diagnostic method is cardiac MRI with late enhancement. Each of these diagnostic methods should be reported in advance.
Therapeutic options include ICD implantation, ablation of ventricular tachycardia using an endocardial or epicardial approach, pharmacological approaches (amiodarone, flecainide, and beta-blockers), and most importantly the management of heart failure. In nearly 40% of cases, different forms of arrhythmogenic cardiomyopathy (arrhythmogenic biventricular cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy) result in severe heart failure that can only be managed with early prophylactic treatment triggered by the genetic findings (phospholamban, lamin A/C, and filamin C mutations).
I am pleased to invite you to submit original manuscripts on the subject of “Arrhythmogenic cardiomyopathy: diagnosis and therapy” for this Special Issue. Full papers, communications, and comprehensive reviews are welcome.
Prof. Stefan Peters
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2200 USD. Submitted manuscripts should be well formatted in good English.
- Catheter Ablation in Arrhythmic Cardiac Diseases: Endocardial and Epicardial AblationWen-Han Cheng, Fa-Po Chung, Yenn-Jiang Lin, Li-Wei Lo, ... Shih-Ann ChenRev. Cardiovasc. Med. 2022, 23(9), 324; https://doi.org/10.31083/j.rcm230932416Download67Views
- A Territory-Wide Study of Arrhythmogenic Right Ventricular Cardiomyopathy Patients from Hong KongIshan Lakhani, Jiandong Zhou, Sharen Lee, Ka Hou Christien Li, ... Gary TseRev. Cardiovasc. Med. 2022, 23(7), 231; https://doi.org/10.31083/j.rcm230723121Download129Views
- Saw-Tooth Cardiomyopathy: the Evidence in the First DecadeZhiyu Liu, Yingying Zheng, Jinying ZhangRev. Cardiovasc. Med. 2022, 23(4), 138; https://doi.org/10.31083/j.rcm230413827Download130Views